IDXG — Interpace Biosciences Share News
0.000.00%
Last trade - 00:00- $45.71m
- $43.06m
- $38.73m
Brief: Ziyad Binsalamah Reports 7.43% Stake In Interpace Diagnostics Group As Of July 21
Brief: Interpace Announces Acceptance Of Seminal Clinical Validation Study For Thyroid Assays
Brief: Interpace Biosciences Reports Qtrly Loss Per Share $2.32
U.S. RESEARCH ROUNDUP- Arch Coal, Glacier Bancorp, IHS Markit
Brief: Interpace Biosciences Announces Full Year And Fourth Quarter 2019 Financial And Business Results And Preliminary Q1-2020 Results
Brief: Interpace Diagnostics Group Says Expects To File 2019 Annual Report No Later Than May 14, 2020
Brief: Interpace Announces Extension Of Labcorp Agreement
Brief: Interpace Biosciences Announces Addition To Board Of Directors And Changes In Leadership
Brief: Interpace Biosciences Enters Into Agreement For $20 Mln Investment
U.S. STOCKS ON THE MOVE-SmileDirectClub, Alphabet, Habit Restaurants, Roku
U.S. STOCKS ON THE MOVE-Halliburton, Cal-Maine Foods, Salesforce.com, Under Armour
U.S. STOCKS ON THE MOVE-Under Armour, Habit Restaurants, Salesforce.com, SmileDirectClub
U.S. STOCKS ON THE MOVE-AutoZone, Nio, SmileDirectClub, Cal-Maine Foods
U.S. STOCKS ON THE MOVE-Nio, Cal-Maine Foods, SmileDirectClub, gold miners
Interpace Biosciences: Gains on plans of collaborative study for diagnostic test
Brief: Interpace Announces Study With University Of North Carolina To Assess Use Of Barregen
Interpace Biosciences: Up on increased Medicare coverage for thyroid cancer test
U.S. STOCKS ON THE MOVE-Boeing, Tallgrass Energy, Immunogen, Mei Pharma
Brief: Interpace Biosciences Expands Strategic Partnership With Genecast Biotechnology